Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study

References

• Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122(23):2451–2455
   PubMedGoogle Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399
   PubMed Web of Science ®Google Scholar
• Tasanarong A, Vohakiat A, Hutayanon P, Piyayotai D. New strategy of alpha- and gamma-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrol Dial Transplant. 2013;28(2):337–344
   PubMedGoogle Scholar
• Guitterez NV, Diaz A, Timmis GC, et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol. 2002;15(5):349–354
   PubMedGoogle Scholar
• Solomon RJ, Mehran R, Natarajan MK, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009;4(7):1162–1169
   PubMed Web of Science ®Google Scholar
• Brown JR, Malenka DJ, DeVries JT, et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: Insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc Interv. 2008;72(3):347–354
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36(5):1542–1548
   PubMed Web of Science ®Google Scholar
• Goldenberg I, Chonchol M, Guetta V. Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol. 2009;29(2):136–144
   PubMed Web of Science ®Google Scholar
• Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329–336
   PubMedGoogle Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491–499
   PubMed Web of Science ®Google Scholar
• Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):59K–77K
   PubMed Web of Science ®Google Scholar
• Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295(23):2765–2779
   PubMed Web of Science ®Google Scholar
• McCullough PA, Akrawinthawong K. Ascorbic acid for the prevention of contrast-induced acute kidney injury. J Am Coll Cardiol 2013;62(23):2176–2177
   PubMedGoogle Scholar
• Akrawinthawong K, Shaw MK, Kachner J, et al. Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: A prospective pilot study. Cardiorenal Med. 2013;3(1):7–16
   PubMed Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis. 2009;54(6):1012–1024
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238
   PubMed Web of Science ®Google Scholar
• Ivanisevic I, Peco-Antic A, Vulicevic I, et al. L-FABP can be an early marker of acute kidney injury in children. Pediatr Nephrol. 2013;28(6):963–969
   PubMedGoogle Scholar
• Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol. 2006;290(2):F517–F529
   PubMed Web of Science ®Google Scholar
• Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol. 2008;3(3):665–673
   PubMed Web of Science ®Google Scholar
• Alharazy SM, Kong N, Saidin R, et al. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease. Angiology. 2014;65(5):436–442
   PubMedGoogle Scholar
• McCullough PA, Williams FJ, Stivers DN, et al. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk. Am J Nephrol. 2012;35(6):509–514
   PubMedGoogle Scholar
• Lameire N, Kellum JA. Contrast-induced acute kidney injury and renal support for acute kidney injury: A KDIGO summary (Part 2). Crit Care. 2013;17(1):205
   PubMed Web of Science ®Google Scholar
• Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 1: Definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27(12):4263–4272
   PubMed Web of Science ®Google Scholar
• Haase M, Devarajan P, Haase-Fielitz A, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol. 2011;57(17):1752–1761
   PubMed Web of Science ®Google Scholar
• Rau S, Habicht A, Kauke T, et al. Neutrophil gelatinase-associated lipocalin and end-stage renal disease: It is not all about the kidneys! Eur J Clin Invest. 2013;43(8):816–820
   PubMedGoogle Scholar
• Liu KD, Yang W, Anderson AH, et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 2013;83(5):909–914
   PubMed Web of Science ®Google Scholar
• Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int. 2007;71(10):967–970
   PubMed Web of Science ®Google Scholar
• Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol. 2010;6(8):602–609
   PubMedGoogle Scholar
• Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009;31(10):910–919
   PubMed Web of Science ®Google Scholar
• Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337–344
   PubMed Web of Science ®Google Scholar
• James MT, Ghali WA, Knudtson ML, et al. Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation. 2011;123(4):409–416
   PubMed Web of Science ®Google Scholar
• Wi J, Ko YG, Kim JS, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97(21):1753–1757
   PubMed Web of Science ®Google Scholar
• Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115(25):3189–3196
   PubMed Web of Science ®Google Scholar
• Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med. 2009;122(9):874.e9–15
   Google Scholar
• Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: A meta-analysis of prospective controlled trials. J Am Soc Nephrol. 2004;15(3):761–769
   PubMedGoogle Scholar
• Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–386
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: Updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527–2541
   PubMed Web of Science ®Google Scholar
• Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med. 1989;110(2):119–124
   PubMed Web of Science ®Google Scholar
• Hardiek KJ, Katholi RE, Robbs RS, Katholi CE. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complicat. 2008;22(3):171–177
   PubMedGoogle Scholar
• Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol. 2009;22(3):333–351
   PubMedGoogle Scholar
• Haase M, Kellum JA, Ronco C. Subclinical AKI – An emerging syndrome with important consequences. Nat Rev Nephrol. 2012;8(12):735–739
   PubMed Web of Science ®Google Scholar
• Ronco C, Stacul F, McCullough PA. Subclinical acute kidney injury (AKI) due to iodine-based contrast media. Eur Radiol. 2013;23(2):319–323
   PubMedGoogle Scholar
• Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care. 2012;16(3):313
   PubMedGoogle Scholar
• McCullough PA, Shaw AD, Haase M, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: Workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2012;182:13–29
   Google Scholar
• McCullough PA, Bouchard J, Waikar SS, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: Executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:5–12
   PubMed Web of Science ®Google Scholar
• Pickering JW, Endre ZH. Linking injury to outcome in acute kidney injury: A matter of sensitivity. PLoS One. 2013;8(4):e62691
   PubMed Web of Science ®Google Scholar